| Title |
Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, September 2021
|
| DOI | 10.1158/1535-7163.mct-21-0201 |
| Pubmed ID | |
| Authors |
Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M. VanderWalde, Hirva Mamdani, Luis E. Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A. Socinski, Jorge J. Nieva, Chul Kim, Antoinette J. Wozniak, Chukwuemeka Ikpeazu, Gilberto de Lima Lopes, Alexander I. Spira, W. Michael Korn, Edward S. Kim, Stephen V. Liu, Hossein Borghaei |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 33% |
| Italy | 3 | 17% |
| Spain | 2 | 11% |
| Colombia | 2 | 11% |
| Austria | 1 | 6% |
| France | 1 | 6% |
| Unknown | 3 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 72% |
| Practitioners (doctors, other healthcare professionals) | 3 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 93 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 11% |
| Student > Bachelor | 6 | 6% |
| Other | 5 | 5% |
| Unspecified | 4 | 4% |
| Researcher | 4 | 4% |
| Other | 15 | 16% |
| Unknown | 49 | 53% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 16 | 17% |
| Medicine and Dentistry | 12 | 13% |
| Unspecified | 4 | 4% |
| Agricultural and Biological Sciences | 2 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 53 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2023.
All research outputs
#3,881,416
of 24,076,257 outputs
Outputs from Molecular Cancer Therapeutics
#725
of 3,946 outputs
Outputs of similar age
#82,316
of 417,673 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#9
of 45 outputs
Altmetric has tracked 24,076,257 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,946 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.